Open AccessSafety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
Author(s) -
LouisPhilippe Boulet,
André Cartier,
Pierre Ernst,
Pierre Larivée,
Michel Laviolette
Publication year - 2004
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2004/823084
Subject(s) - medicine , chlorofluorocarbon , beclometasone dipropionate , asthma , exacerbation , corticosteroid , adverse effect , morning , anesthesia , randomized controlled trial , respiratory disease , lung , physics , meteorology
To compare the systemic safety and efficacy of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extra-fine aerosol 800 microg/day with chlorofluorocarbon (CFC)-BDP 1500 microg/day.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom